January is Glaucoma Awarenss Month
Glaucoma is a leading cause of vision loss and blindness in the United States. Glaucoma has no early symptoms — that’s why half of the people with glaucoma don’t know they have it. The only way to find out if…
Welcome to the “Mehta Verse” – Eyedaptic’s Chief Medical Officer Dr. Mitul Mehta to Present at AAO 2021
Join Eyedaptic’s Chief Medical Officer Dr. Mitul Mehta at AAO 2021 this weekend for his talk, "Augmented Reality and Vision Rehabilitation the Future of Vision Technology”. This onsite presentation shares the results of a clinical study will be shared on…
Eyedaptic’s 3rd Patent Granted
Eyedaptic has been granted a third patent! This patent, along with the others, protects Eyedaptic's intellectual property and low vision technology including Hybrid See Through, which enables Augmented Reality for low vision along with the image processing and machine learning…
Eyedaptic Unveils EYE4 with EyeSwitch™
Eyedaptic launches EYE4, an all-new version of its augmented reality (AR) glasses to address the increasing incidence of vision loss in the US Hands-free visual aid with integrated hand-held magnifier capability uses the power of Augmented Reality and cellular phone…
Eyedaptic Named Orange County Business Journal Innovator of the Year Nominee for the Second Year in a Row
Eyedaptic is honored to be an Orange County Business Journal Innovator of the Year nominee for the second year in a row. The Innovator of the Year program is designed to recognize and celebrate Orange County innovators who are creating…